{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:37:51Z","timestamp":1792798671137,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["(No.81903684)"],"award-info":[{"award-number":["(No.81903684)"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["(No.81903684)"],"award-info":[{"award-number":["(No.81903684)"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Hospital Pharmacy Research Foundation of Changzhou Siyao Hospital and Nanjing Pharmaceutical Association","award":["(2019YX019)"],"award-info":[{"award-number":["(2019YX019)"]}]},{"name":"the Hospital Pharmacy Research Foundation of Changzhou Siyao Hospital and Nanjing Pharmaceutical Association","award":["(2019YX019)"],"award-info":[{"award-number":["(2019YX019)"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["(021414380498)"],"award-info":[{"award-number":["(021414380498)"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["(021414380498)"],"award-info":[{"award-number":["(021414380498)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00210-023-02450-4","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T10:02:53Z","timestamp":1681380173000},"page":"2379-2391","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Silymarin ameliorates peritoneal fibrosis by inhibiting the TGF-\u03b2\/Smad signaling pathway"],"prefix":"10.1007","volume":"396","author":[{"given":"Yingwen","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"TingYang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"2450_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4103\/ijp.IJP_660_16","volume":"50","author":"S Anwar","year":"2018","unstructured":"Anwar S, Madkor HR, Ahmed N, Wagih ME (2018) In vivo anticlastogenic effect of silymarin from milk thistle Silybum marianum L. Indian J Pharmacol 50:108\u2013115. https:\/\/doi.org\/10.4103\/ijp.IJP_660_16","journal-title":"Indian J Pharmacol"},{"key":"2450_CR2","doi-asserted-by":"publisher","unstructured":"Balzer MS (2020) Molecular pathways in peritoneal fibrosis. Cell Signal 75:109778. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109778","DOI":"10.1016\/j.cellsig.2020.109778"},{"key":"2450_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.foodres.2017.07.017","volume":"100","author":"CS Chambers","year":"2017","unstructured":"Chambers CS, Hole\u010dkov\u00e1 V, Petr\u00e1skov\u00e1 L, Biedermann D, Valentov\u00e1 K, Buchta M, K\u0159en V (2017) The silymarin composition\u2026 and why does it matter??? Food Res Int 100:339\u2013353. https:\/\/doi.org\/10.1016\/j.foodres.2017.07.017","journal-title":"Food Res Int"},{"key":"2450_CR4","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/jsfa.4723","volume":"92","author":"IS Chen","year":"2012","unstructured":"Chen IS, Chen YC, Chou CH, Chuang RF, Sheen LY, Chiu CH (2012) Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis. J Sci Food Agric 92:1441\u20131447. https:\/\/doi.org\/10.1002\/jsfa.4723","journal-title":"J Sci Food Agric"},{"key":"2450_CR5","doi-asserted-by":"publisher","unstructured":"Chen Y, Chen L, Yang T (2021) Silymarin nanoliposomes attenuate renal injury on diabetic nephropathy rats via co-suppressing TGF-\u03b2\/Smad and JAK2\/STAT3\/SOCS1 pathway. Life Sci 271: 119197. https:\/\/doi.org\/10.1016\/j.lfs.2021.119197","DOI":"10.1016\/j.lfs.2021.119197"},{"key":"2450_CR6","doi-asserted-by":"publisher","unstructured":"Chen X, Yang Q, Bai W, Yao W, Liu L, Xing Y, Meng C, Qi P, Dang Y, Qi X (2022) Dapagliflozin attenuates myocardial fibrosis by inhibiting the TGF-\u03b21\/Smad signaling pathway in a normoglycemic rabbit model of chronic heart failure. Front Pharmacol 13: 873108. https:\/\/doi.org\/10.3389\/fphar.2022.873108","DOI":"10.3389\/fphar.2022.873108"},{"key":"2450_CR7","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1089\/jmf.2015.0104","volume":"19","author":"S Clichici","year":"2016","unstructured":"Clichici S, Olteanu D, Filip A, Nagy AL, Oros A, Mircea PA (2016) Beneficial effects of silymarin after the discontinuation of CCl4-induced liver fibrosis. J Med Food 19:789\u2013797. https:\/\/doi.org\/10.1089\/jmf.2015.0104","journal-title":"J Med Food"},{"key":"2450_CR8","doi-asserted-by":"publisher","unstructured":"Costalonga EC, de Freitas LJ, Aragone DDSP, Silva FMO, Noronha IL (2017) Anti-fibrotic effects of valproic acid in experimental peritoneal fibrosis. PLoS One 12: e0184302. https:\/\/doi.org\/10.1371\/journal.pone.0184302","DOI":"10.1371\/journal.pone.0184302"},{"key":"2450_CR9","doi-asserted-by":"publisher","unstructured":"Dou F, Ding Y, Wang C, Duan J, Wang W, Xu H, Zhao X, Wang J, Wen A (2020) Chrysophanol ameliorates renal interstitial fibrosis by inhibiting the TGF-\u03b2\/Smad signaling pathway. Biochem Pharmacol 180: 114079. https:\/\/doi.org\/10.1016\/j.bcp.2020.114079","DOI":"10.1016\/j.bcp.2020.114079"},{"key":"2450_CR10","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s12325-020-01251-y","volume":"37","author":"A Gillessen","year":"2020","unstructured":"Gillessen A, Schmidt HH (2020) Silymarin as supportive treatment in liver diseases: a narrative review. Adv Ther 37:1279\u20131301. https:\/\/doi.org\/10.1007\/s12325-020-01251-y","journal-title":"Adv Ther"},{"key":"2450_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/jcp.28976","volume":"235","author":"N Jiang","year":"2020","unstructured":"Jiang N, Zhang Z, Shao X, Jing R, Wang C, Fang W, Mou S, Ni Z (2020) Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-\u03b21\/Smad3 signaling pathway. J Cell Physiol 235:364\u2013379. https:\/\/doi.org\/10.1002\/jcp.28976","journal-title":"J Cell Physiol"},{"key":"2450_CR12","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1177\/089686080702702s15","volume":"2","author":"K Kaneko","year":"2007","unstructured":"Kaneko K, Hamada C, Tomino Y (2007) Peritoneal fibrosis intervention. Perit Dial Int 2:S82\u2013S86","journal-title":"Perit Dial Int"},{"key":"2450_CR13","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.3390\/ijms18122527","volume":"18","author":"H Kang","year":"2017","unstructured":"Kang H (2017) Role of MicroRNAs in TGF-\u03b2 signaling pathway-mediated pulmonary fibrosis. Int J Mol Sci 18:2527. https:\/\/doi.org\/10.3390\/ijms18122527","journal-title":"Int J Mol Sci"},{"key":"2450_CR14","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.fct.2017.06.016","volume":"106","author":"JW Ko","year":"2017","unstructured":"Ko JW, Shin NR, Park SH, Lee IC, Ryu JM, Kim HJ, Cho YK, Kim JC, Shin IS (2017) Silibinin inhibits the fibrotic responses induced by cigarette smoke via suppression of TGF-\u03b21\/Smad 2\/3 signaling. Food Chem Toxicol 106:424\u2013429. https:\/\/doi.org\/10.1016\/j.fct.2017.06.016","journal-title":"Food Chem Toxicol"},{"key":"2450_CR15","doi-asserted-by":"publisher","unstructured":"Li Y, Wang L, Zhang Q, Tian L, Gan C, Liu H, Yin W, Ye T(2022) Blueberry juice attenuates pulmonary fibrosis via blocking the TGF-\u03b21\/Smad signaling pathway. Front Pharmacol 13:825915. https:\/\/doi.org\/10.3389\/fphar.2022.825915","DOI":"10.3389\/fphar.2022.825915"},{"key":"2450_CR16","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3390\/molecules24081552","volume":"24","author":"CH Liu","year":"2020","unstructured":"Liu CH, Jassey A, Hsu HY, Lin LT (2020a) Antiviral activities of silymarin and derivatives. Molecules 24:1552. https:\/\/doi.org\/10.3390\/molecules24081552","journal-title":"Molecules"},{"key":"2450_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2147\/DDDT.S224308","volume":"14","author":"R Liu","year":"2020","unstructured":"Liu R, Wang Q, Ding Z, Zhang X, Li Y, Zang Y, Zhang G (2020b) Silibinin augments the antifibrotic effect of valsartan through inactivation of TGF-\u03b21 signaling in kidney. Drug Des Devel Ther 14:603\u2013611. https:\/\/doi.org\/10.2147\/DDDT.S224308","journal-title":"Drug Des Devel Ther"},{"key":"2450_CR18","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1681\/ASN.2016010112","volume":"27","author":"R Mehrotra","year":"2016","unstructured":"Mehrotra R, Devuyst O, Davies SJ, Johnson DW (2016) The current state of peritoneal dialysis. J Am Soc Nephrol 27:3238\u20133252. https:\/\/doi.org\/10.1681\/ASN.2016010112","journal-title":"J Am Soc Nephrol"},{"key":"2450_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/cbin.11079","volume":"43","author":"S Meng","year":"2019","unstructured":"Meng S, Yang F, Wang Y, Qin Y, Xian H, Che H, Wang L (2019) Silymarin ameliorates diabetic cardiomyopathy via inhibiting TGF-\u03b21\/Smad signaling. Cell Biol Int 43:65\u201372. https:\/\/doi.org\/10.1002\/cbin.11079","journal-title":"Cell Biol Int"},{"key":"2450_CR20","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/sj.ki.5002533","volume":"72","author":"J Nie","year":"2007","unstructured":"Nie J, Dou X, Hao W, Wang X, Peng W, Jia Z, Chen W, Li X, Luo N, Lan HY, Yu XQ (2007) Smad7 gene transfer inhibits peritoneal fibrosis. Kidney Int 72:1336\u20131344. https:\/\/doi.org\/10.1038\/sj.ki.5002533","journal-title":"Kidney Int"},{"key":"2450_CR21","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3390\/jof8101010","volume":"8","author":"VQ Resende","year":"2022","unstructured":"Resende VQ, Reis-Goes KH, Finato AC, de F\u00e1tima A-D, Dos Santos AR, Perico J, Amorim BC, Venturini J (2022) Combined silymarin and cotrimoxazole therapy attenuates pulmonary fibrosis in experimental paracoccidioidomycosis. J Fungi (basel) 8:1010. https:\/\/doi.org\/10.3390\/jof8101010","journal-title":"J Fungi (basel)"},{"key":"2450_CR22","doi-asserted-by":"publisher","unstructured":"Shi Y, Hu Y, Wang Y, Ma X, Tang L, Tao M, Qiu A, Zhuang S, Liu N (2021) Blockade of autophagy prevents the development and progression of peritoneal fibrosis. Front Pharmacol 12: 724141. https:\/\/doi.org\/10.3389\/fphar.2021.724141","DOI":"10.3389\/fphar.2021.724141"},{"key":"2450_CR23","doi-asserted-by":"publisher","first-page":"3543678","DOI":"10.1155\/2016\/3543678","volume":"2016","author":"R Strippoli","year":"2016","unstructured":"Strippoli R, Moreno-Vicente R, Battistelli C, Cicchini C, Noce V, Amicone L, Marchetti A, Del Pozo MA, Tripodi M (2016) Molecular mechanisms underlying peritoneal EMT and fibrosis. Stem Cells Int 2016:3543678. https:\/\/doi.org\/10.1155\/2016\/3543678","journal-title":"Stem Cells Int"},{"key":"2450_CR24","doi-asserted-by":"publisher","first-page":"F457","DOI":"10.1152\/ajprenal.00425.2019","volume":"318","author":"W Su","year":"2020","unstructured":"Su W, Wang H, Feng Z, Sun J (2020) Nitro-oleic acid inhibits the high glucose-induced epithelial-mesenchymal transition in peritoneal mesothelial cells and attenuates peritoneal fibrosis. Am J Physiol Renal Physiol 318:F457\u2013F467. https:\/\/doi.org\/10.1152\/ajprenal.00425.2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"2450_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000203362","volume":"30","author":"Y Sun","year":"2009","unstructured":"Sun Y, Zhu F, Yu X, Nie J, Huang F, Li X, Luo N, Lan HY, Wang Y (2009) Treatment of established peritoneal fibrosis by gene transfer of Smad7 in a rat model of peritoneal dialysis. Am J Nephrol 30:84\u201394. https:\/\/doi.org\/10.1159\/000203362","journal-title":"Am J Nephrol"},{"key":"2450_CR26","doi-asserted-by":"publisher","unstructured":"Terri M, Trionfetti F, Montaldo C, Cordani M, Tripodi M, Lopez-Cabrera M, Strippoli R (2021) Mechanisms of peritoneal fibrosis: focus on immune cells-peritoneal stroma interactions. Front Immunol 12: 607204. https:\/\/doi.org\/10.3389\/fimmu.2021.607204","DOI":"10.3389\/fimmu.2021.607204"},{"key":"2450_CR27","doi-asserted-by":"publisher","unstructured":"Tighe SP, Akhtar D, Iqbal U, Ahmed A (2020a) Chronic liver disease and silymarin: a biochemical and clinical review. J Clin Transl Hepatol 8: 454\u2013458. https:\/\/doi.org\/10.14218\/JCTH.2020.00012","DOI":"10.14218\/JCTH.2020.00012"},{"key":"2450_CR28","doi-asserted-by":"publisher","unstructured":"Tighe SP, Akhtar D, Iqbal U, Ahmed A (2020b) Chronic liver disease and silymarin: a biochemical and clinical review. J Clin Transl Hepatol 8:454\u2013458. https:\/\/doi.org\/10.14218\/JCTH.2020.00012","DOI":"10.14218\/JCTH.2020.00012"},{"key":"2450_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10157-011-0533-y","volume":"16","author":"Y Tomino","year":"2012","unstructured":"Tomino Y (2012) Mechanisms and interventions in peritoneal fibrosis. Clin Exp Nephrol 16:109\u2013114","journal-title":"Clin Exp Nephrol"},{"key":"2450_CR30","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.jhep.2009.02.023","volume":"50","author":"M Trappoliere","year":"2009","unstructured":"Trappoliere M, Caligiuri A, Schmid M, Bertolani C, Failli P, Vizzutti F, Novo E, di Manzano C, Marra F, Loguercio C, Pinzani M (2009) Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells. J Hepatol 50:1102\u20131111. https:\/\/doi.org\/10.1016\/j.jhep.2009.02.023","journal-title":"J Hepatol"},{"key":"2450_CR31","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10157-011-0533-y","volume":"10","author":"K Tzavlaki","year":"2020","unstructured":"Tzavlaki K, Moustakas A (2020) TGF-\u03b2 Signaling Biomolecules 10:487. https:\/\/doi.org\/10.1007\/s10157-011-0533-y","journal-title":"TGF-\u03b2 Signaling Biomolecules"},{"key":"2450_CR32","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/ptr.4829","volume":"27","author":"JI Tzeng","year":"2013","unstructured":"Tzeng JI, Chen MF, Chung HH, Cheng JT (2013) Silymarin decreases connective tissue growth factor to improve liver fibrosis in rats treated with carbon tetrachloride. Phytother Res 27:1023\u20131028. https:\/\/doi.org\/10.1002\/ptr.4829","journal-title":"Phytother Res"},{"key":"2450_CR33","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3389\/fphar.2018.00422","volume":"9","author":"H Ullah","year":"2018","unstructured":"Ullah H, Khan H (2018) Anti-Parkinson potential of silymarin: mechanistic insight and therapeutic standing. Front Pharmacol 9:422. https:\/\/doi.org\/10.3389\/fphar.2018.00422","journal-title":"Front Pharmacol"},{"key":"2450_CR34","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.3390\/molecules27165327","volume":"27","author":"K Wadhwa","year":"2022","unstructured":"Wadhwa K, Pahwa R, Kumar M, Kumar S, Sharma PC, Singh G, Verma R, Mittal V, Singh I, Kaushik D, Jeandet P (2022) Mechanistic insights into the pharmacological significance of silymarin. Molecules 27:5327. https:\/\/doi.org\/10.3390\/molecules27165327","journal-title":"Molecules"},{"key":"2450_CR35","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1111\/jcmm.13393","volume":"22","author":"J Wu","year":"2018","unstructured":"Wu J, Xing C, Zhang L, Mao H, Chen X, Liang M, Wang F, Ren H, Cui H, Jiang A, Wang Z, Zou M, Ji Y (2018) Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis. J Cell Mol Med 22:1190\u20131201. https:\/\/doi.org\/10.1111\/jcmm.13393","journal-title":"J Cell Mol Med"},{"key":"2450_CR36","doi-asserted-by":"publisher","first-page":"508","DOI":"10.37290\/ctnr2641-452X.19:508-513","volume":"19","author":"J Wu","year":"2021","unstructured":"Wu J, Huang C, Kan GX, Han Y, Zhang X, Yang J (2021) Silymarin regulates TGF-\u03b21\/Smad3 signaling pathway and improves renal tubular interstitial fibrosis caused by obstructive nephropathy. Curr Top Nutraceut R 19:508\u2013513","journal-title":"Curr Top Nutraceut R"},{"key":"2450_CR37","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.3390\/molecules24203693","volume":"24","author":"Y Xie","year":"2019","unstructured":"Xie Y, Zhang D, Zhang J, Yuan J (2019) Metabolism, transport and drug-drug interactions of silymarin. Molecules 24:3693. https:\/\/doi.org\/10.3390\/molecules24203693","journal-title":"Molecules"},{"key":"2450_CR38","doi-asserted-by":"publisher","unstructured":"Yu JW, Duan WJ, Huang XR, Meng XM, Yu XQ, Lan HY (2014) MicroRNA-29b inhibits peritoneal fibrosis in a mouse model of peritoneal dialysis.Lab Invest 94: 978\u201390. https:\/\/doi.org\/10.1038\/labinvest.2014.91","DOI":"10.1038\/labinvest.2014.91"},{"key":"2450_CR39","doi-asserted-by":"publisher","unstructured":"Zhang Y, Huang Q, Chen Y, Peng X, Wang Y, Li S, Wu J, Luo C, Gong W, Yin B, Xiao J, Zhou W, Peng F, Long H (2020) Parthenolide, an NF-\u03baB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-\u03b2\/Smad pathway. Int Immunopharmacol 78: 106064. https:\/\/doi.org\/10.1016\/j.intimp.2019.106064","DOI":"10.1016\/j.intimp.2019.106064"},{"key":"2450_CR40","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/1440-1681.12448","volume":"42","author":"F Zhao","year":"2015","unstructured":"Zhao F, Shi D, Li T, Li L, Zhao M (2015) Silymarin attenuates paraquat-induced lung injury via Nrf2-mediated pathway in vivo and in vitro. Clin Exp Pharmacol Physiol 42:988\u2013998. https:\/\/doi.org\/10.1111\/1440-1681.12448","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2450_CR41","first-page":"11941","volume":"10","author":"XA Zhao","year":"2017","unstructured":"Zhao XA, Chen GM, Liu Y, Chen YX, Wu HY, Chen J, Xiong YL, Tian C, Wang GY, Jia B, Xia J, Wang J, Yan XM, Zhang ZP, Huang R, Wu C (2017) Inhibitory effect of silymarin on CCl4-induced liver fibrosis by reducing Ly6Chi monocytes infiltration. Int J Clin Exp Pathol 10:11941\u201311951","journal-title":"Int J Clin Exp Pathol"},{"key":"2450_CR42","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.kint.2016.03.040","volume":"90","author":"Q Zhou","year":"2016","unstructured":"Zhou Q, Bajo MA, Del Peso G, Yu X, Selgas R (2016) Preventing peritoneal membrane fibrosis in peritoneal dialysis patients. Kidney Int 90:515\u2013524. https:\/\/doi.org\/10.1016\/j.kint.2016.03.040","journal-title":"Kidney Int"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02450-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02450-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02450-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T10:04:10Z","timestamp":1694513050000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02450-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["2450"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02450-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]},"assertion":[{"value":"31 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}